Logo of jophLink to Publisher's site
PMC full text:

Table 1.

Pharmacokinetic Parameters of Lifitegrast Calculated for Various Ocular Tissues and Plasma for Each Formulation

 Formulation No. 1Formulation No. 2
TissueCmax(ng/mL or ng/g)tmax(h)AUC0-8 (ng·h/mL or ng·h/g)t1/2(h)aCmax(ng/mL or ng/g)tmax(h)AUC0-8 (ng·h/mL or ng·h/g)t1/2(h)a
Conjunctiva (palpebral)11,9000.25030,8009,6200.25036,600
Cornea5,9300.25025,5005,1901.0015,200
Sclera (anterior)11,2000.25017,5001.975,8700.50011,2002.32
Conjunctiva (bulbar)14,2000.25013,4002.029,3700.25012,000
Sclera (posterior)8260.2502,3603690.5001,570
Iris-ciliary body1900.2501,1301951.00778
Aqueous humor79.03.0053089.51.00340
Choroid-RPE1190.25049245.93.00231
Plasma17.40.25011.20.8509.520.25016.4
Lens3.851.005.440.7943.00NR
Optic nerve36.01.00NR10.80.250NR
Retina31.21.00NRNRNRNR
Vitreous humor2.090.250NR0.3720.250NR
aCould not be calculated for most tissues due to the lack of a distinct elimination phase.

AUC0–8, area under the concentration-time curve from 0 to 8 h; choroid-RPE, choroid-retinal pigment epithelium; Cmax, maximum concentration; NR, not reported due to limited measurable data; tmax, time to maximum concentration.